, Tracking Stock Market Picks
Enter Symbol:
Haemonetics Corporation (HAE) [hlAlert]

up 141.12 %

Haemonetics Corporation (HAE) rated Buy with price target $75 by Maxim Group

Posted on: Tuesday,  Feb 3, 2009  9:25 AM ET by Maxim Group

Maxim Group rated Buy Haemonetics Corporation (NYSE: HAE) on 02/03/2009. Previously Maxim Group rated Buy Haemonetics Corporation (NYSE: HAE) on 01/28/2009.,
when the stock price was $14.98. Since then, Haemonetics Corporation has gained 141.12% as of 01/06/2016's recent price of $36.12.
If you would have followed the previous Maxim Group's recommendation on HAE, you would have gained 141.12% of your investment in 2534 days.

Haemonetics is a global company engaged in the design, manufacture and worldwide marketing of automated blood processing systems. These systems address important medical markets: surgical blood salvage, blood component collections and plasma collections. The majority of their business is outside the US.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/3/2009 9:25 AM Buy
15.92 18.75
as of 12/31/2009
1 Week up  5.81 %
1 Month up  10.47 %
3 Months up  5.07 %
1 YTD down  -7.36 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2009 8:25 AM Buy
14.98 18.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy